Valuation: Byotrol plc

Market Cap 194K 256K 225K 207K 363K 24.15M 371K 2.49M 962K 11.94M 961K 940K 41.39M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.12M 979K 902K 1.58M 105M 1.62M 10.85M 4.2M 52.05M 4.19M 4.1M 180M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 01/07/2024
Director TitleAgeSince
Director/Board Member 50 13/12/2021
Chairman 75 22/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
+0.35%-0.90%-6.78%-0.65% 347B
-0.99%+3.61%-8.58%-0.97% 131B
+1.11%+2.89%+3.79%+21.29% 73.67B
-1.05%-1.54%-6.25%-19.67% 54.15B
+0.90%+5.57%-8.38%-25.85% 36.73B
-1.18%-5.03%+0.56%-58.46% 29.14B
-1.44%+2.16%+4.66%-4.03% 19.46B
-0.73%+5.22%-29.72%-37.59% 18.82B
+0.53%+7.10%+0.67%+23.79% 18.31B
Average -2.72%+2.33%-5.56%-11.35% 80.97B
Weighted average by Cap. -0.67%+1.16%-5.88%-3.91%

Financials

2023 2024
Net sales 4.59M 6.07M 5.32M 4.9M 8.61M 572M 8.79M 58.95M 22.81M 283M 22.79M 22.29M 981M 3.97M 5.25M 4.6M 4.24M 7.44M 495M 7.6M 50.97M 19.72M 245M 19.7M 19.27M 848M
Net income -1.69M -2.24M -1.96M -1.81M -3.17M -211M -3.24M -21.72M -8.41M -104M -8.4M -8.21M -362M -3.06M -4.05M -3.55M -3.27M -5.75M -382M -5.86M -39.34M -15.22M -189M -15.21M -14.87M -655M
Net Debt 287K 379K 333K 307K 538K 35.78M 549K 3.68M 1.43M 17.68M 1.42M 1.39M 61.32M 651K 860K 754K 695K 1.22M 81.16M 1.25M 8.36M 3.23M 40.11M 3.23M 3.16M 139M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35